Opinion  |  08/11/2023

Position Statement on New Genomic Techniques and Intellectual Property Law

A new Position Statement of the Institute addresses concerns related to intellectual property protection for genome-editing technologies and genome-edited plants in the EU. It proposes a set of policy recommendations to facilitate access to and utilisation of IP-protected genome-editing technologies and their products in the plant breeding sector.

Symbolic image of genome editing. Image: vchalup/Adobe Stock
Symbolic image of genome editing. Image: vchalup/Adobe Stock

On 5 July 2023, the European Commission issued a proposal for the regulation that intends to relax the requirements for marketing authorisation of plants obtained by certain new genomic techniques (NGTs) in the EU. While NGTs are expected to become more appealing to breeders and farmers, the complexity of the intellectual property (IP) landscape surrounding NGTs and resulting products can have a discouraging effect on innovation. In view of numerous concerns related to IP protection for NGTs and NGT-derived plants, a research group at the Institute has developed a set of policy recommendations that can facilitate access to and utilisation of IP-protected NGTs and their products in the plant breeding sector.


To the Position Statement:
Position Statement (8 August 2023) on New Genomic Techniques and Intellectual Property Law: Challenges and Solutions for the Plant Breeding Sector


More on this topic:
CRISPR/Cas Technology and Innovation: Mapping Patent Law Issues